Catégorie
Fluvoxamine
Numéro CAS
1217262-11-7
Formule moléculaire
C₁₇H₂₆F₃N₃O₂
Masse moléculaire
361.40 g/mol
Synonyme

N-[2-[[[(1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]ethyl]ethane-1,2-diamine; (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-{2-[(2-aminoethyl)amino]ethyl}oxime; N-(Ethylamino) Fluvoxamine

Mots-clés
Aromatics
Amines
Fine Chemicals
Pharmaceutical Standards
Intermediates
Impurities
slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Fluvoxamine EP Impurity F is a related impurity of fluvoxamine that may be formed during the synthesis, processing, or storage of the drug substance. It is identified and monitored through analytical quality-control methods to ensure the purity and stability of fluvoxamine. Controlling this impurity helps maintain the quality of the active pharmaceutical ingredient (API) and meet relevant pharmacopoeial specifications.